Poland· PL-100521847
Alyftrek
A other respiratory system products product containing deutivacaftor + tezacaftorum + vanzacaftor, registered in Poland by Vertex Pharmaceuticals (Ireland) Limited. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Deutivacaftor + tezacaftorum + vanzacaftor is registered in 6 of 19 countries.
Countries holding a registration under ATC R07AX (other respiratory system products), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Deutivacaftor + tezacaftorum + vanzacaftor · ATC R07AX
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Deutivacaftor + Tezacaftorum + Vanzacaftor
- Manufacturer
- Vertex Pharmaceuticals (Ireland) Limited
- Country
- Poland (PL)
- ATC code
- R07AX
- ATC class
- Other respiratory system products
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin00351167179000
- gtin00351167171806
- gtin00351167180808
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Deutivacaftor + tezacaftorum + vanzacaftor in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesALYFTREKVertex Pharmaceuticals Incorporated
- CzechiaALYFTREKVertex Pharmaceuticals (Ireland) Limited, Dublin
- FinlandAlyftrekVertex Pharmaceuticals (Ireland) Limited
- United KingdomAlyftrek 125mg/50mg/10mg tabletsVertex Pharmaceuticals (Europe) Ltd
- IrelandAlyftrek 125 mg/50 mg/10 mg film-coated tabletsVertex Pharmaceuticals (Ireland) Limited
- SwitzerlandAlyftrek
- NetherlandsAlyftrek 125 mg/50 mg/10 mg filmomhulde tablettenVertex Pharmaceuticals (Ireland) Limited
- NorwayAlyftrekVertex Pharmaceuticals (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Alyftrek
- Liechtenstein · Alyftrek
- Norway · Alyftrek
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f3e429ea-93dc-4937-829e-51606ba65588 GET /v1/drugs/f3e429ea-93dc-4937-829e-51606ba65588?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg + 20 mg + 4 mg",
"packaging": "00351167179000 ¦ Rpz ¦ EU/1/25/1943/001 ¦ 162923\n84 tabl.\n¦ UR/Z/4b/206/25 - 00351167171806 ¦ UR/Z/4b/207/25 - 00351167180808",
"substance": "Deutivacaftor 50 mg + Tezacaftorum 20 mg + Vanzacaftor 4 mg",
"common_name": "Deutivacaftor + Tezacaftorum + Vanzacaftor",
"pl_product_id": "100521847",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about deutivacaftor + tezacaftorum + vanzacaftor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.